Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer

Anticancer Research

Volumn 32, Issue 1, 2012, Pages 153-161

  Lindquist, David ^a,b,d   Ährlund Richter, Andreas ^b   Tarján, Miklós ^c   Tot, Tibor ^c   Dalianis, Tina ^b  

^a Center for Clinical Research Dalarna   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c FALUN HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

Author keywords

CD44; EGFR; p16; p27; Tonsillar cancer; VEGF

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; KI 67 ANTIGEN; PROTEIN P27; UVOMORULIN; VASCULOTROPIN;

ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TONGUE CANCER; TONSIL CANCER; WART VIRUS;

ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PALATINE TONSIL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; SURVIVAL RATE; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84855682328     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Hammarstedt L, Dahlstrand H, Lindquist D, Onelov L, Ryott M, Luo J, Dalianis T, Ye W and Munck-Wikland E: The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 127(9): 988-992, 2007. (Pubitemid 47345807)
2. WHO: IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Lyon (France): International Agency for Research on Cancer 38: 35-394, 1986.
3. WHO: IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Human Papillomaviruses. Lyon (France): International Agency for Research on Cancer 90: 45-179, 2007.
4. Frisch M, Hjalgrim H, Jaeger AB and Biggar RJ: Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 11(6): 489-495, 2000. (Pubitemid 30342838)
5. Syrjanen S: HPV infections and tonsillar carcinoma. J Clin Pathol 57(5): 449-455, 2004.
6. Braakhuis BJ, Visser O and Leemans CR: Oral and oropharyngeal cancer in the Netherlands between 1989 and 2006: Increasing incidence, but not in young adults. Oral Oncol 45(9): e85-89, 2009.
7. Conway DI, Stockton DL, Warnakulasuriya KA, Ogden G and Macpherson LM: Incidence of oral and oropharyngeal cancer in the United Kingdom (1990-1999) - recent trends and regional variation. Oral Oncol 42(6): 586-592, 2006. (Pubitemid 43965006)
8. Robinson KL and Macfarlane GJ: Oropharyngeal cancer incidence and mortality in Scotland: Are rates still increasing? Oral Oncol 39(1): 31-36, 2003. (Pubitemid 35379816)
9. Attner P, Du J, Nasman A, Hammarstedt L, Ramqvist T, Lindholm J, Marklund L, Dalianis T and Munck-Wikland E: The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer 126(12): 2879-2884, 2011.
10. Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J, Creson N, Lindholm J, Ye W, Dalianis T and Munck-Wikland E: Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119(11): 2620-2623, 2006. (Pubitemid 44691317)
11. Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, Ramqvist T, Lindholm J, Sparen P, Ye W, Dahlstrand H, Munck-Wikland E and Dalianis T: Incidence of human papillomavirus (HPV)-positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125(2): 362-366, 2009.
12. Ramqvist T and Dalianis T: Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis 16(11): 1671-1677, 2010.
13. Dahlgren L, Dahlstrand HM, Lindquist D, Hogmo A, Bjornestal L, Lindholm J, Lundberg B, Dalianis T and Munck-Wikland E: Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 112(6): 1015-1019, 2004. (Pubitemid 39507008)
14. Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, Eckel HE, Dienes HP, Pfister HJ and Fuchs PG: Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 92(11): 2875-2884, 2001.
15. Ragin CC and Taioli E: Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 121(8): 1813-1820, 2007. (Pubitemid 47417302)
16. Lindquist D, Romanitan M, Hammarstedt L, Nasman A, Dahlstrand H, Lindholm J, Onelov L, Ramqvist T, Ye W, Munck-Wikland E and Dalianis T: Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol 1(3): 350-355, 2007. (Pubitemid 350186274)
17. Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M and Dalianis T: Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102(2): 152-158, 2002.
18. Mellin H, Friesland S, Lewensohn R, Dalianis T and Munck-Wikland E: Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89(3): 300-304, 2000. (Pubitemid 30430748)
19. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV and Sidransky D: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92(9): 709-720, 2000. (Pubitemid 30365531)
20. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP and Gillison ML: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1): 24-35, 2010.
21. Dahlstrand HM and Dalianis T: Presence and influence of human papillomaviruses (HPV) in tonsillar cancer. Adv Cancer Res 93: 59-89, 2005. (Pubitemid 41557272)
22. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, Klein W, Helbig M, Dietz A, Weidauer H and Bosch FX: Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58(1): 5-13, 1998. (Pubitemid 28027707)
23. Begum S, Cao D, Gillison M, Zahurak M and Westra WH: Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 11(16): 5694-5699, 2005. (Pubitemid 41170292)
24. Klussmann JP, Gultekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, Eckel HE, Pfister HJ and Fuchs PG: Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 162(3): 747-753, 2003. (Pubitemid 36237483)
25. Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL and Psyrri A: Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 24(5): 736-747, 2006. (Pubitemid 46622040)
26. Mellin Dahlstrand H, Lindquist D, Bjornestal L, Ohlsson A, Dalianis T, Munck-Wikland E and Elmberger G: P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. Anticancer Res 25(6C): 4375-4383, 2005. (Pubitemid 41729481)
27. Kumar B, Cordell KG, Ue JS, Worden FP, Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JM, D'Silva NJ, Yang K, Kurnit DM, Bauer JA, Bradford CR and Carey TE: EGFR, p16, HPV titer, BCL-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 26(19): 3128-3137, 2008.
28. Chu IM, Hengst L and Slingerland JM: The CDK inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 8(4): 253-267, 2008. (Pubitemid 351430863)
29. Zoller M: CD44: Can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11(4): 254-267, 2011.
30. Carinci F, Stabellini G, Calvitti M, Pelucchi S, Targa L, Farina A, Pezzetti F and Pastore A: CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma. J Craniofac Surg 13(1): 85-89, 2002. (Pubitemid 34873952)
31. Kawano T, Nakamura Y, Yanoma S, Kubota A, Furukawa M, Miyagi Y and Tsukuda M: Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer. Auris Nasus Larynx 31(1): 35-41, 2004. (Pubitemid 38369373)
32. Hong A, Dobbins T, Lee CS, Jones D, Jackson E, Clark J, Armstrong B, Harnett G, Milross C, O'Brien C and Rose B: Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer. Eur J Cancer 46(11): 2088-2096, 2010.
33. Kong CS, Narasimhan B, Cao H, Kwok S, Erickson JP, Koong A, Pourmand N and Le QT: The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 74(2): 553-561, 2009.
34. Ashraf MJ, Maghbul M, Azarpira N and Khademi B: Expression of Ki67 and P53 in primary squamous cell carcinoma of the larynx. Indian J Pathol Microbiol 53(4): 661-665, 2010.
35. Gallo O, Masini E, Bianchi B, Bruschini L, Paglierani M and Franchi A: Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol 33(7): 708-714, 2002. (Pubitemid 34953350)
36. Kyzas PA, Cunha IW and Ioannidis JP: Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis. Clin Cancer Res 11(4): 1434-1440, 2005. (Pubitemid 40315223)
37. Mineta H, Miura K, Suzuki I, Takebayashi S, Amano H, Araki K, Harada H, Ichimura K, Wennerberg JP and Dictor MR: Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. Cancer 85(5): 1011-1017, 1999. (Pubitemid 29115577)
38. Motta Rda R, Zettler CG, Cambruzzi E, Jotz GP and Berni RB: Ki-67 and p53 correlation prognostic value in squamous cell carcinomas of the oral cavity and tongue. Braz J Otorhinolaryngol. 75(4): 544-549, 2009.
39. Muramatsu H, Akimoto T, Maebayashi K, Kita M and Mitsuhashi N: Prognostic significance of dysadherin and Ecadherin expression in patients with head and neck cancer treated by radiation therapy. Anticancer Res 28(6B): 3859-3864, 2008.
40. Barlow L, Westergren K, Holmberg L and Talback M: The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48(1): 27-33, 2009.
41. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ and Snijders PJ: The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76(4): 1057-1062, 1995.
42. Tieben LM, ter Schegget J, Minnaar RP, Bouwes Bavinck JN, Berkhout RJ, Vermeer BJ, Jebbink MF and Smits HL: Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 42(2-3): 265-279, 1993.
43. Ramqvist T, Du J, Lunden M, Ahrlund-Richter S, Ferreira J, Marions L, Sparen P, Andersson S and Dalianis T: Prevaccination prevalence of human papillomavirus types in the genital tract of 15-23 year-old women attending a youth health clinic in Stockholm, Sweden. Scand J Infect Dis 43(2): 115-121, 2011.
44. Dahlgren L, Mellin H, Wangsa D, Heselmeyer-Haddad K, Bjornestal L, Lindholm J, Munck-Wikland E, Auer G, Ried T and Dalianis T: Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors. Int J Cancer 707(2): 244-249, 2003. (Pubitemid 37152904)
45. Lindstrom AK, Ekman K, Stendahl U, Tot T, Henriksson R, Hedman H and Hellberg D: LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking. Int J Gynecol Cancer 18(2): 312-317, 2008. (Pubitemid 351365217)
46. Stoll C, Baretton G, Soost F, Terpe HJ, Domide P and Lohrs U: Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas. Oral Oncol 35(5): 484-489, 1999. (Pubitemid 29386784)
47. de Jong MC, Pramana J, van der Wal JE, Lacko M, Peutz-Kootstra CJ, de Jong JM, Takes RP, Kaanders JH, van der Laan BF, Wachters J, Jansen JC, Rasch CR, van Velthuysen ML, Grenman R, Hoebers FJ, Schuuring E, van den Brekel MW and Begg AC: CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res 16(21): 5329-5338, 2010.
48. Perisanidis C, Perisanidis B, Wrba F, Brandstetter A, El Gazzar S, Papadogeorgakis N, Seemann R, Ewers R, Kyzas PA and Filipits M: Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki 67 in oral and oropharyngeal squamous cell carcinoma. J Oral Pathol Med [Epub ahead of print], 2011.